Total Synthesis and Biological Evaluation of the Anti-Inflammatory (13R,14S,15R)‑13-Hydroxy-14-deoxyoxacyclododecindione

The first total synthesis of the natural product (13R,14S,15R)-13-hydroxy-14-deoxyoxacyclo­dodecindione, which was isolated in 2018 as a member of the oxacyclo­dodecindione family, is reported. A synthetic strategy through intramolecular Friedel-Crafts acylation combined with the stereoselective synthesis of a new triol key fragment allowed the preparation of the macrolactone. Due to mismatching physical data of the synthetic product, a revision of the configuration of the natural product isolated in 2018 is required. Light-induced E/Z-isomerism of the macrolactone backbone is described for the first time in the class of oxacyclo­dodecindione-type macrolactones. The hydroxylated macrolactone prepared herein was found to show highly promising IC50 values in biological assays addressing the inhibition of inflammatory responses.